Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. reduced its position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 32.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,871 shares of the company’s stock after selling 75,178 shares during the period. Connor […]
Connor Clark & Lunn Investment Management Ltd. reduced its position in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 32.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 156,871 shares of the company’s stock after selling 75,178 shares during the period. Connor […]
